1 / 7

Frontier Pharma: Parkinsons Disease - Identifying and Commer

The Parkinsons disease (PD) pipeline currently has 302 products in active development across all stages, but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident.

hsdfg
Download Presentation

Frontier Pharma: Parkinsons Disease - Identifying and Commer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Category : Healthcare Frontier Pharma: Parkinsons Disease - Identifying and Commercializing First-in-Class Innovation

  2. Synopsis The Parkinsons disease (PD) pipeline currently has 302 products in active development across all stages, but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market relies on symptomatic treatments that target neuromodulatory receptors, the pipeline shows a diverse range of neuroprotective therapies targeting dysfunctional disease processes. Browse complete Report http://www.aarkstore.com/healthcare/89790/frontier-pharma-parkinsons-disease-identifying-and-commercializing-first-in-class-innovation

  3. Summary PD is a complex and multifaceted disease with a complex interplay between different pathological processes. Enormous research efforts and significant technological advances have furthered knowledge of the neuroanatomy of the basal ganglia and of the fundamental processes underlying neurodegeneration, helped by the ongoing identification of susceptibility genes and causative genes in familial PD. Although the exact mechanisms that initiate onset remain unclear, these insights have been translated into the pool of novel therapeutic targets, which may potentially become disease-modifying therapies by aligning to the disease processes and some genetic determinants of PD.

  4. Table of contents 1.1 List of Tables 31.2 List of Figures 32 Executive Summary 52.1 Highly Innovative and Diverse Pipeline 52.2 Alignment of Innovation to Disease Processes and Genetics 52.3 Deals Landscape Present Substantial Investment Opportunities 5

  5. Related Reports • http://www.aarkstore.com/healthcare/111115/healthcare-regulatory-and-reimbursement-landscape-norway • http://www.aarkstore.com/healthcare/111114/arthoscopic-devices-market-by-product-by-end-user • http://www.aarkstore.com/healthcare/111113/north-american-joint-reconstruction-market • http://www.aarkstore.com/healthcare/111111/north-american-trauma-fixation-devices-market-by-types-by-end-users • http://www.aarkstore.com/healthcare/111108/north-american-dermatology-treatment-devices-market

  6. Frontier Pharma: Parkinsons Disease - Identifying and Commercializing First-in-Class Innovation Published: Dec 2014 – 121 Pages The Parkinsons disease (PD) pipeline currently has 302 products in active development across all stages, but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident Price

  7. Contact Us Office Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit http://www.aarkstore.com OR Mail us at contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news

More Related